| |
Original Artikel |
Journal |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
Chemical and Pharmaceutical Bulletin |
2025―Aug―08 |
Novel Approach to Pre-Exposure Prophylaxis (PrEP) of COVID-19: Development of S-892216 Long-Acting Injectable Suspension |
Ryo Ohashi, Ryosuke Watari, Daisuke Kondo, Shuichi Otake, Tatsuhiko Murata, Go Kimura |
| 2 |
[GO] |
Biological and Pharmaceutical Bulletin |
2025―Jul―09 |
Identification of FDA-Approved Drugs That Inhibit SARS-CoV-2 and Human Norovirus Replication |
Tsuyoshi Hayashi, Junki Hirano, Kosuke Murakami, Yoshiki Fujii, Sakura Kobayashi, Takashi Tanikawa, Masashi Kitamura, Yuichi Someya |
| 3 |
[GO] |
Biological and Pharmaceutical Bulletin |
2025―Mai―16 |
Treatment of Long Coronavirus Disease in Japan: A Nationwide Study of Symptom-Associated Drug Prescriptions |
Yuka Kogure, Wataru Ando, Kyoka Sakamaki, Mitsuhiro Sugawara |
| 4 |
[GO] |
Biological and Pharmaceutical Bulletin |
2025―Apr―23 |
Evaluation of the Influence of the National Action Plan on Antimicrobial Resistance and the COVID-19 Pandemic on the Consumption of Broad-Spectrum Antimicrobial and Anti-methicillin-resistant <i>Staphylococcus aureus</i> Agents |
Ryota Goto, Ryo Inose, Ryuji Koizumi, Keisuke Sawada, Masahiro Ishikane, Norio Ohmagari, Yuichi Muraki |
| 5 |
[GO] |
Biological and Pharmaceutical Bulletin |
2024―Nov―07 |
Sunflower Trypsin Monocyclic Inhibitor Selected for the Main Protease of SARS-CoV-2 by Phage Display |
Graziele Cristina Ferreira, Verônica de Moraes Manzato, Debora Noma Okamoto, Livia Rosa Fernandes, Deivid Martins Santos, Gabriel Cerqueira Alves Costa, Fernando Allan Abreu Silva, Ricardo Jose Soares Torquato, Giuseppe Palmisano, Maria Aparecida Juliano, Aparecida Sadae Tanaka |
| 6 |
[GO] |
YAKUGAKU ZASSHI |
2024―Jun―30 |
Actual Access and Usage of Antipyretic Analgesics before and after COVID-19 Vaccination: Pharmacist’s Roles in Promoting Proper Use of Medicines during the Infodemic","新型コロナワクチン接種に伴う解熱鎮痛薬の入手・使用実態：インフォデミックでの医薬品適正使用のための薬剤師の役割の考察 |
Kyoko Izumisawa, Natsuyo Yanagi, Hiroki Satoh, Yasufumi Sawada |
| 7 |
[GO] |
Chemical and Pharmaceutical Bulletin |
2024―Jun―11 |
<i>In vitro and in silico</i> study of new biscoumarin glycosides from <i>Paramignya trimera</i> against Angiotensin-converting enzyme 2 (ACE-2) for preventing SARS-CoV-2 infection |
Nguyen Xuan Ha, Tran Thu Huong, Pham Ngoc Khanh, Nguyen Phi Hung, Vu Thanh Loc, Vu Thi Ha, Dang Thu Quynh, Do Huu Nghi, Pham-The Hai, Christopher J. Scarlett, Ludger A. Wessjohann, Nguyen Manh Cuong |
| 8 |
[GO] |
Biological and Pharmaceutical Bulletin |
2024―Mai―16 |
Computational Estimation of Residues Involving Resistance to the SARS-CoV-2 Main Protease Inhibitor Ensitrelvir Based on Virtual Alanine Scan of the Active Site |
Ayato Mizuno, Tomoki Nakayoshi, Koichi Kato, Eiji Kurimoto, Akifumi Oda |
| 9 |
[GO] |
Biological and Pharmaceutical Bulletin |
2024―Mai―16 |
Ciclesonide Inhibits SARS-CoV-2 Papain-Like Protease <i>in Vitro</i> |
Yuka Kiba, Takashi Tanikawa, Masashi Kitamura |
| 10 |
[GO] |
Biological and Pharmaceutical Bulletin |
2024―Apr―30 |
Current Status and Perspectives of Therapeutic Antibodies Targeting the Spike Protein S2 Subunit against SARS-CoV-2 |
Yuichiro Yamamoto, Tetsuya Inoue |
| 11 |
[GO] |
Biological and Pharmaceutical Bulletin |
2024―Apr―30 |
Inhibition Mechanism of SARS-CoV-2 Infection by a Cholesterol Derivative, Nat-20(S)-yne |
Mana Murae, Shota Sakai, Non Miyata, Yoshimi Shimizu, Yuko Okemoto-Nakamura, Takuma Kishimoto, Motohiko Ogawa, Hideki Tani, Kazuma Tanaka, Kohji Noguchi, Masayoshi Fukasawa |
| 12 |
[GO] |
YAKUGAKU ZASSHI |
2023―Nov―30 |
ウィズコロナ時代の新たな医療に対応できる人材の育成を目指した臨床準備教育におけるオンライン服薬指導実習の試み","A Trial of Practical Training on Online Medication Instructions in Clinical Preparatory Education: Development of Human Resources to Provide New Forms of Medical Care after the COVID-19 Pandemic |
Susumu Kawano, Hiroaki Kaji, Takayoshi Maiguma, Keisuke Yoshii, Yuichi Tasaka, Yasuhisa Izushi, Yoshihisa Kitamura, Hideki Nawa, Kenichi Shimada, Tohru Nakanishi, Shuji Mori, Etsuko Suzaki, Sumiko Shiota |
| 13 |
[GO] |
YAKUGAKU ZASSHI |
2023―Nov―30 |
COVID-19流行前後での薬局薬剤師の医療対応の変化に関するアンケート調査","Changes in Attitudes to Medical Care among Pharmacy Pharmacists before and after the COVID-19 Pandemic: A Questionnaire Survey |
Yu Norikoshi, Yuji Matsunaga, Yuji Uchida, Fukuko Horio, Makoto Anraku, Kanami Suruki, Ichiro Inaba, Yoshiro Nagata, Tokunori Ikeda |
| 14 |
[GO] |
Chemical and Pharmaceutical Bulletin |
2023―Nov―30 |
Exploratory Studies of Effective Inhibitors against the SARS-CoV-2 Main Protease by Halogen Incorporation and Amide Bond Replacement |
Kohei Tsuji, Takuya Kobayakawa, Takahiro Ishii, Nobuyo Higashi-Kuwata, Chika Azuma, Kouki Shinohara, Yutaro Miura, Kenichi Yamamoto, Soshi Nishimura, Shin-ichiro Hattori, Haydar Bulut, Hiroaki Mitsuya, Hirokazu Tamamura |
| 15 |
[GO] |
Chemical and Pharmaceutical Bulletin |
2023―Nov―30 |
<i>In Silico</i> Identification of Inhibitory Compounds for SARS-Cov-2 Papain-Like Protease |
Kazunori Miwa, Yan Guo, Masayuki Hata, Yoshinori Hirano, Norio Yamamoto, Tyuji Hoshino |
| 16 |
[GO] |
BPB Reports |
2023―Nov―21 |
Corrigendum: An <i>in Vitro </i>Short-Term Treatment with Black Tea-Derived Theaflavins Reduced Infectivity of SARS-CoV-2 in Saliva |
Motohiko Ogawa, Mana Murae, Shuetsu Fukushi, Kohji Noguchi, Hideki Ebihara, Masayoshi Fukasawa |
| 17 |
[GO] |
Biological and Pharmaceutical Bulletin |
2023―Okt―20 |
Removal of soluble ACE2 in VeroE6 cells by 17β-estradiol reduces SARS-CoV-2 infectivity |
Yuta Kyosei, Teruki Yoshimura, Etsuro Ito |
| 18 |
[GO] |
BPB Reports |
2023―Okt―05 |
An <i>in Vitro</i> Short-Term Treatment with Black Tea-Derived Theaflavins Reduced Infectivity of SARS-CoV-2 in Saliva |
Motohiko Ogawa, Mana Murae, Shuetsu Fukushi, Kohji Noguchi, Hideki Ebihara, Masayoshi Fukasawa |
| 19 |
[GO] |
YAKUGAKU ZASSHI |
2023―Aug―31 |
かかりつけ薬剤師制度が新型コロナウイルス感染症流行下の脂質異常症患者のアドヒアランスに及ぼす影響","Effect of a Family Pharmacist System on Medication Adherence of Patients with Dyslipidemia during a COVID-19 Epidemic |
Mamoru Maeda, Yoshitaka Hasegawa, Ryota Tsukioka, Miya Oishi |
| 20 |
[GO] |
Chemical and Pharmaceutical Bulletin |
2023―Apr―30 |
Computational Screening of Inhibitory Compounds for SARS-Cov-2 3CL Protease with a Database Consisting of Approved and Investigational Chemicals |
Kazunori Miwa, Yan Guo, Masayuki Hata, Norio Yamamoto, Tyuji Hoshino |
| 21 |
[GO] |
BPB Reports |
2023―Apr―06 |
Survey on Headache During COVID-19 Infection in People with Chronic Headache |
Masakazu Ishii, Ikumi Ito, Hirotaka Katoh |
| 22 |
[GO] |
YAKUGAKU ZASSHI |
2023―Feb―28 |
Pharmacokinetic Study of Antiviral Drugs in Patients with COVID-19 |
Kei Irie |
| 23 |
[GO] |
BPB Reports |
2023―Jan―22 |
Inhibitory Effects of Olive-Derived Phytochemicals on SARS-CoV-2 3C-Like Protease (3CL<sup>pro</sup>) |
Yoshimitsu Kiriyama, Hiromi Nochi |
| 24 |
[GO] |
Biological and Pharmaceutical Bulletin |
2022―Okt―07 |
Safety of remdesivir in 20 children with COVID-19 -case series- |
Shuji Manabe, Shinsuke Mizuno, Tsuyoshi Jinda, Masashi Kasai |
| 25 |
[GO] |
YAKUGAKU ZASSHI |
2022―Sep―30 |
Significant Prolongation of the International Normalized Ratio Associated with COVID-19 Treatment: Possible Drug Interaction with Remdesivir |
Hidetoshi Ishii, Norio Yokota, Yuki Bando, Katsuya Otori |
| 26 |
[GO] |
Chemical and Pharmaceutical Bulletin |
2022―Sep―30 |
Cyclic Phthalate Esters as Liver X Receptor Antagonists with Anti-hepatitis C Virus and Anti-severe Acute Respiratory Syndrome Coronavirus 2 Properties |
Shiki Saito, Hirofumi Ohashi, Kou Nakamura, Junichiro Otagaki, Kazane Nishioka, Kota Nishiuchi, Ayaka Nakamura, Yukine Tsurukawa, Hisanobu Shibasaki, Hironobu Murakami, Masaki Nagane, Maiko Okada, Kouji Kuramochi, Koichi Watashi, Shinji Kamisuki |
| 27 |
[GO] |
Biological and Pharmaceutical Bulletin |
2022―Sep―30 |
Dihydroceramide Δ4-Desaturase 1 Is Not Involved in SARS-CoV-2 Infection |
Yasuhiro Hayashi, Kouki Matsuda, Kazunari Tanigawa, Takashi Tanikawa, Kenji Maeda, Kiyoto Tsuchiya |
| 28 |
[GO] |
YAKUGAKU ZASSHI |
2022―Jul―31 |
Investigation of Foreign Particles in Moderna COVID-19 Vaccine |
Hiroko Shibata, Yusuke Nomura, Tsuyoshi Kawakami, Eiichi Yamamoto, Daisuke Ando, Nahoko Uchiyama, Hiroko Tokumoto, Tatsuo Koide, Hideyuki Sakoda, Hiroyuki Yoshida, Yasuhiro Abe, Takashi Hakamatsuka, Yoshiaki Ikarashi, Yuji Haishima, Akiko Ishii-Watabe, Ken-ichi Izutsu, Masamitsu Honma, Yukihiro Goda |
| 29 |
[GO] |
BPB Reports |
2022―Jul―11 |
Establishment of an Easy and Convenient Anti-SARS-CoV-2 Neutralizing Antibodies Test Flow Starting from Community Pharmacies: Expansion of Pharmacy Functions Suitable During the Novel Coronavirus Era |
Kazuyuki Niki, Kozo Tada, Katsumi Suezawa, Tomoko Kasashima, Shin Fujisue, Eri Seichi, Miki Nakahara, Yoshiko Ohara, Akiko Yoshida, Mikiko Ueda |
| 30 |
[GO] |
Biological and Pharmaceutical Bulletin |
2022―Jun―30 |
Evaluation of a Webinar for Pharmacists Learning Basic Clinical-Oncology during COVID-19 Pandemic in Japan |
Hideyuki Terazono, Masami Tsuchiya, Yosuke Maki, Naoki Yoshikawa, Yosuke Kawahara, Keiko Nishimura, Keisuke Shinohara, Daisuke Ogawa, Riho Mori, Yoshihiro Iwamoto, Fumio Itagaki, Hiroyuki Masuko, Masahito Yonemura, Mayako Uchida |
| 31 |
[GO] |
YAKUGAKU ZASSHI |
2022―Mai―31 |
Development and Evaluation about “2nd-wave” COVID-19 Vaccines |
Yasuhiro Araki |
| 32 |
[GO] |
YAKUGAKU ZASSHI |
2022―Mai―31 |
The Expert of the Medicine Explains “Understanding of the Novel Coronavirus Vaccine” |
Mariko Takeda-Morishita, Yoshinobu Takakura |
| 33 |
[GO] |
YAKUGAKU ZASSHI |
2022―Mai―31 |
What Is an Antibody Test? Characteristics of Antibodies against SARS-CoV-2 and Their Tests |
Akiko Ishii-Watabe |
| 34 |
[GO] |
YAKUGAKU ZASSHI |
2022―Mai―31 |
Compliance with Vaccination against SARS-CoV-2; Information Transmission Based on Scientific Evidence and Its Difficulty |
Itsuko Ishii |
| 35 |
[GO] |
Biological and Pharmaceutical Bulletin |
2022―Jan―21 |
Simultaneous Screening of SARS-CoV-2 Omicron and Delta Variants Using High-Resolution Melting Analysis |
Akira Aoki, Yoko Mori, Yoshinori Okamoto, Hideto Jinno |
| 36 |
[GO] |
YAKUGAKU ZASSHI |
2021―Dez―31 |
Polio Environmental Surveillance and Its Application to SARS-CoV-2 Detection |
Hiromu Yoshida |
| 37 |
[GO] |
Chemical and Pharmaceutical Bulletin |
2021―Dez―24 |
In vitro and in silico studies of potential coronavirus-specific 3C-like protease inhibitors |
Shoji Maehara, Manami Kobayashi, Mari Kuwada, Tominari Choshi, Hirohumi Inoue, Yuzou Hieda, Takashi Nishiyama, Toshiyuki Hata |
| 38 |
[GO] |
Chemical and Pharmaceutical Bulletin |
2021―Dez―20 |
Application of Acoustic Ejection MS System to High-Throughput Screening for SARS-CoV-2 3CL Protease Inhibitors |
Tsukasa Hasegawa, Riyo M. Imamura, Tateki Suzuki, Takao Hashiguchi, Takao Nomura, Satoko Otsuguro, Katsumi Maenaka, Michihito Sasaki, Yasuko Orba, Hirofumi Sawa, Akihiko Sato, Takayoshi Okabe, Tetsuo Nagano, Hirotatsu Kojima |
| 39 |
[GO] |
Biological and Pharmaceutical Bulletin |
2021―Jun―30 |
Remote Reminiscence Using Immersive Virtual Reality May Be Efficacious for Reducing Anxiety in Patients with Mild Cognitive Impairment Even in COVID-19 Pandemic: A Case Report |
Megumi Yahara, Kazuyuki Niki, Keita Ueno, Mio Okamoto, Takeshi Okuda, Hiroyuki Tanaka, Yasuo Naito, Ryouhei Ishii, Mikiko Ueda, Toshinori Ito |
| 40 |
[GO] |
Biological and Pharmaceutical Bulletin |
2021―Jun―18 |
Improved detection sensitivity of an antigen test for SARS-CoV-2 nucleocapsid proteins with thio-NAD cycling |
Yuta Kyosei, Mayuri Namba, Sou Yamura, Satoshi Watabe, Teruki Yoshimura, Tadahiro Sasaki, Tatsuo Shioda, Etsuro Ito |
| 41 |
[GO] |
BPB Reports |
2021―Mai―25 |
Verification of MA-T Safety and Efficacy Against Pathogens Including SARS-CoV-2 |
Takekatsu Shibata, Ryuta Urakawa, Chikako Ono, Yukihiro Akeda, Takayoshi Sakai, Shigeto Hamaguchi, Kiyoto Takamori, Tsuyoshi Inoue, Kazunori Tomono, Kiyoshi Konishi, Yoshiharu Matsuura |
| 42 |
[GO] |
Chemical and Pharmaceutical Bulletin |
2021―Feb―28 |
Impact of COVID-19 Outbreak on the Long-Range Transport of Common Air Pollutants in KUWAMS |
Hao Zhang, Lulu Zhang, Lu Yang, Quanyu Zhou, Xuan Zhang, Wanli Xing, Kazuichi Hayakawa, Akira Toriba, Ning Tang |
